Eli Lilly Shares Down 7.5% as Market Reacts to Slashed Q4 Forecast

1 day ago · Shares of Eli Lilly are down 7.6% today, reflecting market disappointment in the company's adjusted guidance for the fourth quarter of 2024.The pharmaceutical giant expects …

5%
OFF

Eli Lilly Shares Down 7.5% As Market Reacts To Slashed Q4 Forecast

2 weeks from now

1 day ago · Shares of Eli Lilly are down 7.6% today, reflecting market disappointment in the company's adjusted guidance for the fourth quarter of 2024.The pharmaceutical giant expects …

yahoo.com

7%
OFF

Eli Lilly And Company (NYSE:LLY) Shares Down 0.7% - MarketBeat

2 weeks from now

Dec 12, 2024 · Eli Lilly and Company (NYSE:LLY - Get Free Report)'s share price traded down 0.7% during trading on Thursday . The stock traded as low as $790.50 and last traded at …

marketbeat.com

5%
OFF

Eli Lilly And Company (NYSE:LLY) Trading Down 1.5% - MarketBeat

2 weeks from now

3 days ago · The company has a debt-to-equity ratio of 2.03, a current ratio of 1.27 and a quick ratio of 0.97. The company's fifty day moving average price is $785.91 and its 200-day moving …

marketbeat.com

7%
OFF

After Eli Lilly's 7% Slump On Its Guidance Cut, What's Left To

2 weeks from now

19 hours ago · There's still a lot to like about Eli Lilly stock, an analyst said Wednesday after the weight-loss drugs kingpin cut its sales view. ... Eli Lilly (NYSE: LLY) is the most valuable …

yahoo.com

6%
OFF

Eli Lilly And Company (NYSE:LLY) Trading Down 0.6% - Time To Sell?

2 weeks from now

Dec 31, 2024 · Eli Lilly and Company Stock Down 0.2 %. The company has a debt-to-equity ratio of 2.03, a quick ratio of 0.97 and a current ratio of 1.27. The stock has a 50-day moving …

marketbeat.com

6%
OFF

What's Happening With LLY Stock - Nasdaq

2 weeks from now

9 hours ago · Eli Lilly stock (NYSE: LLY) fell over 6% on Tuesday, January 14, after it announced that the sales of its obesity drugs are seeing slower than anticipated growth. It has adjusted its …

nasdaq.com

6%
OFF

Why Did Eli Lilly Stock Fall 6%? - Nasdaq

2 weeks from now

Nov 1, 2024 · Eli Lilly stock (NYSE: LLY) fell over 6% on Wednesday, October 30, after it posted downbeat results. The company reported revenue of $11.4 billion and adjusted earnings of …

nasdaq.com

$700
OFF

Eli Lilly: Big 2025 Ahead, But Execution Risks Exist

2 weeks from now

16 hours ago · Eli Lilly has regularly traded down to the $700 to $750 range over the last year. The stock isn't necessarily cheap at 33x the 2025 EPS target of $22.62, but the company is …

seekingalpha.com

8%
OFF

Eli Lilly Misses Drug Sales Forecast, Shares Drop Over 8%

2 weeks from now

1 day ago · Eli Lilly’s shares dropped over 8% on lower-than-expected drug sales forecasts. Analysts had projected $7.43 billion in combined sales for Zepbound and Mounjaro; Lilly …

nasdaq.com

9%
OFF

Eli Lilly And Company (NYSE:LLY) Shares Down 5.9% - Here's Why

2 weeks from now

2 days ago · Check Out Our Latest Analysis on Eli Lilly and Company Eli Lilly and Company Stock Down 7.5 %. Pfizer: 4 Reasons to Buy This Stock ; The company has a current ratio of 1.27, a …

marketbeat.com

16%
OFF

Eli Lilly (LLY) Stock Price Prediction And Forecast 2025-2030

2 weeks from now

20 hours ago · Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 465.16% and currently trading at $747.20.The company has been …

247wallst.com

5%
OFF

Eli Lilly And Company (NYSE:LLY) Shares Down 1.5% - Here's Why

2 weeks from now

1 day ago · Barclays reduced their target price on Eli Lilly and Company from $1,025.00 to $975.00 and set an "overweight" rating for the company in a report on Thursday, October 31st. …

marketbeat.com

8%
OFF

Eli Lilly And Company (NYSE:LLY) Stock Price Down 0.8% - Here's …

2 weeks from now

Dec 27, 2024 · Shares of Eli Lilly and Company (NYSE:LLY - Get Free Report) traded down 0.8% on Friday . The company traded as low as $786.01 and last traded at $788.02. 455,472 shares …

marketbeat.com

7%
OFF

Eli Lilly And Company (NYSE:LLY) Trading 0.7% Higher - MarketBeat

2 weeks from now

18 hours ago · Eli Lilly and Company (NYSE:LLY - Get Free Report)'s stock price shot up 0.7% during trading on Wednesday . The company traded as high as $754.60 and last traded at …

marketbeat.com

FAQs about Eli Lilly Shares Down 7.5% as Market Reacts to Slashed Q4 Forecast Coupon?

Why is Eli Lilly (LLY) stock down?

Eli Lilly and Company (LLY) stock is down in Wednesday's premarket trading after the pharmaceutical company reported third quarter results that missed revenue expectations. The disappointing performance was driven by lower-than-anticipated sales of the company's weight loss drug, Zepbound. ...

How did Eli Lilly and Company's stock perform in 2024?

Eli Lilly and Company's stock was trading at $582.92 on January 1st, 2024. Since then, LLY shares have increased by 33.6% and is now trading at $779.02. How were Eli Lilly and Company's earnings last quarter? Eli Lilly and Company (NYSE:LLY) released its earnings results on Wednesday, October, 30th. ...

Can Eli Lilly buy back 2% of its shares?

Eli Lilly and Company's board initiated a stock buyback program on Monday, December 9th 2024, which permits the company to buy back $15,000,000,000 in shares, according to EventVestor. This means that the company could buy up to 2% of its shares through open market purchases. ...

Is Eli Lilly a good stock to buy?

Has Eli Lilly Stock Peaked? Eli Lilly (NYSE: LLY) is the most valuable healthcare stock in the world, with a market capitalization of around $720 billion. For a while, it looked like it might be on track to be the first healthcare company to top a $1 trillion valuation, perhaps as early as this year. ...

How much money did Eli Lilly make in the first year?

The company brought in $4,470 in its first year and saw that figure grow 10X over the next 3. Among the many innovations during this time period is the addition of gelation coatings for pills which helped set the company up for rapid expansion. The company was incorporated in 1881 as Eli Lilly and Company issuing stock to family and friends. ...

Why did Eli Lilly's stock drop in Q4?

Eli Lilly and Company's stock dipped due to cutting Q4 sales targets despite a strong 2024 performance from drugs Mounjaro and Zepbound. The biopharma forecasts 2025 revenue of $58-$61 billion for 32% sales growth, driven by significant production increases in the first half. ...